ClinConnect ClinConnect Logo
Search / Trial NCT05444387

The Effect of Upper Limb Loading During Partial Body Weight Support Treadmill Training in Children With Cerebral Palsy

Launched by ALYA ABDELGHAFOUR ALKHAJEH · Jun 30, 2022

Trial Information

Current as of June 19, 2025

Unknown status

Keywords

ClinConnect Summary

Cerebral Palsy (CP) is a non-progressive neurodevelopmental disorder which affects the child's motor and sensory system, and consequently posture and walking. The underlying etiology is considered multifactorial, and no specific etiological factor has been blamed. While it may be seen in the prenatal, neonatal, and postnatal period, prenatal factors account for 70 to 80 % of all cases. Although the incidence of cerebral palsy widely varies worldwide, it has been often estimated as 1.5 to 2.5/1000. While the prevalence in young people is as high as 74%. One of the characteristics of CP is ga...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of CP confirmed by the neurologist
  • Age between 4 to 8 years
  • Both genders
  • The level of gross motor function is between level I and II according to Gross Motor Function Classification System (GMFCS)
  • The degree of spasticity according to Modified Ashworth Scale range between grade 1 and grade 2
  • Children should be cognitively competent with IQ level not less than 60% and able to understand and follow instructions, as well as, in general they are cooperative
  • Only Arabic and English speakers will be recruited in the study
  • Exclusion Criteria:
  • Had any orthopedic surgery or spasticity altering procedure in the previous 12 months
  • Children with visual, auditory, vestibular or perceptual deficits.

About Alya Abdelghafour Alkhajeh

Alya Abdelghafour Alkhajeh is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in healthcare and extensive experience in clinical trial management, Alya's focus is on ensuring the highest standards of compliance, safety, and efficacy throughout the research process. Passionate about fostering innovation, she collaborates with multidisciplinary teams to facilitate the development of groundbreaking therapies. Her leadership and strategic vision contribute to the successful execution of trials that address critical health challenges and enhance the understanding of therapeutic interventions.

Locations

Sharjah, , United Arab Emirates

Patients applied

0 patients applied

Trial Officials

Fatma Hegazy

Principal Investigator

UOS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials